Farther Finance Advisors LLC Has $3.18 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Farther Finance Advisors LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 81.7% during the second quarter, Holdings Channel reports. The institutional investor owned 5,845 shares of the medical equipment provider’s stock after purchasing an additional 2,629 shares during the period. Farther Finance Advisors LLC’s holdings in Intuitive Surgical were worth $3,176,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the period. Global Financial Private Client LLC raised its stake in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the period. Elite Financial Inc. acquired a new position in Intuitive Surgical during the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, TD Capital Management LLC raised its stake in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the firm’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the sale, the director owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $438.72 on Monday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market capitalization of $157.27 billion, a PE ratio of 61.19, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61. The business’s fifty day moving average is $476.64 and its 200 day moving average is $503.43.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the business posted $1.78 earnings per share. The firm’s revenue was up 21.4% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ISRG. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. BTIG Research increased their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. Finally, Evercore ISI increased their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.